牛牛AI助理已提取核心訊息
On January 4, 2024, Cardio Diagnostics Holdings, Inc. and YA II PN, Ltd., an affiliate of Yorkville Advisors Global, LP, mutually agreed to terminate their Securities Purchase Agreement originally dated March 8, 2023. The agreement, which had facilitated the issue and sale of a $5.0 million Convertible Debenture by Cardio Diagnostics to Yorkville, also outlined the conditions for a second Convertible Debenture worth $6.2 million. However, the first debenture has been fully repaid and the obligations for the second debenture have now been nullified with no outstanding borrowings, advance notices, or shares to be issued. The termination of the agreement did not incur any fees for either party.
On January 4, 2024, Cardio Diagnostics Holdings, Inc. and YA II PN, Ltd., an affiliate of Yorkville Advisors Global, LP, mutually agreed to terminate their Securities Purchase Agreement originally dated March 8, 2023. The agreement, which had facilitated the issue and sale of a $5.0 million Convertible Debenture by Cardio Diagnostics to Yorkville, also outlined the conditions for a second Convertible Debenture worth $6.2 million. However, the first debenture has been fully repaid and the obligations for the second debenture have now been nullified with no outstanding borrowings, advance notices, or shares to be issued. The termination of the agreement did not incur any fees for either party.
2024年1月4日，Cardio Diagnostics Holdings, Inc.和Yorkville Advisors Global, Lp的子公司YA II PN, Ltd.共同同意終止其原定於2023年3月8日簽訂的證券購買協議。該協議爲Cardio Diagnostics向約克維爾發行和出售500萬美元的可轉換債券提供了便利，還概述了第二張價值620萬美元的可轉換債券的條件。但是，第一張債券已全部償還，第二張債券的債務現已無效，沒有未償還的借款、預先通知或股票可供發行。協議的終止不會對任何一方產生任何費用。
2024年1月4日，Cardio Diagnostics Holdings, Inc.和Yorkville Advisors Global, Lp的子公司YA II PN, Ltd.共同同意終止其原定於2023年3月8日簽訂的證券購買協議。該協議爲Cardio Diagnostics向約克維爾發行和出售500萬美元的可轉換債券提供了便利，還概述了第二張價值620萬美元的可轉換債券的條件。但是，第一張債券已全部償還，第二張債券的債務現已無效，沒有未償還的借款、預先通知或股票可供發行。協議的終止不會對任何一方產生任何費用。
有用
沒用
